MNTA’s request for confidential treatment pertains to an amendment to the partnership agreement with CSL to develop M230; this is redacted the SEC filing:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.